These 10 medtech companies care a lot about research

November 29, 2017 By Chris Newmarker

5. Abiomed

R&D spend: $50.0 million

Percent of revenues: 15.1%

2017 overall revenue rank: 89

Abiomed (Nasdaq: ABMD) touts its Impella heart pumps as the world’s smallest – with more than 60,000 patients treated so far. The Impella device is meant to help restore blood flow and allow the heart to rest after a heart attack, according to the Danvers, Mass.–based company. Snaked through the femoral or axillary artery, the device spins at 50,000 revolutions per minute as it sits in the heart. It sends blood away from the heart and out to the body.

Next>>

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.